本页面由Tiger Trade Technology Pte. Ltd.提供服务

Aclaris Therapeutics

5.32
-0.1850-3.36%
盘后5.320.00000.00%19:43 EDT
成交量:327.82万
成交额:1,740.99万
市值:7.83亿
市盈率:-9.08
高:5.60
开:5.50
低:5.17
收:5.51
52周最高:6.60
52周最低:1.74
股本:1.47亿
流通股本:1.10亿
量比:1.36
换手率:2.98%
股息:- -
股息率:- -
每股收益(TTM):-0.5861
每股收益(LYR):-0.5300
净资产收益率:-59.10%
总资产收益率:-28.98%
市净率:6.29
市盈率(LYR):-10.04

数据加载中...

2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/05

重要事件披露

Form 8-K - Current report
2024/02/05

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/02/01

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/19

重要事件披露

Form 8-K - Current report
2024/01/16

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/20

重要事件披露

Form 8-K - Current report
2023/12/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/11

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/25

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/13

重要事件披露

Form 8-K - Current report
2023/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/06

重要事件披露

Form 8-K - Current report
2023/10/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/18

重要事件披露

Form 8-K - Current report
2023/09/05

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/07

重要事件披露

Form 8-K - Current report